Save the date: Orion’s Capital Markets Day 2023
ORION CORPORATION INVESTOR NEWS 9 FEBRUARY 2023 at 12.30                      Save the date: Orion’s Capital Markets…
ORION CORPORATION INVESTOR NEWS 9 FEBRUARY 2023 at 12.30                      Save the date: Orion’s Capital Markets…
ORION CORPORATIONÂ Â STOCK EXCHANGE RELEASE / NOTICE TO GENERAL MEETING 9 FEBRUARY 2023 at 12:15…
ORION CORPORATIONÂ Â Â Â Â Â Â Â FINANCIAL STATEMENT RELEASE 2022Â Â Â Â Â Â Â Â 9 FEBRUARY 2023Â at 12:00 EET Orion Group Financial Statement Release 2022…
Subskribe replaces legacy system, enabling productivity gains and a frictionless user experience SAN RAMON, Calif.,…
Cloud-native solution will enhance Aptean’s Food & Beverage ERP offerings ALPHARETTA, Ga., Feb. 09, 2023…
Internet City, Dubai–(Newsfile Corp. – February 9, 2023) – LBank Exchange, a global digital asset…
H2Ocean LLC has published a clinical study on the efficacy of their sea salt-based nasal…
Toronto, Ontario–(Newsfile Corp. – February 9, 2023) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
TOKYO, Feb 9, 2023 – (JCN Newswire) – Mitsubishi Power, a power solutions brand of…
DUBAI, Feb 9, 2023 – (ACN Newswire) – The Rare Antiquities is revolutionising the way…
DUBAI, Feb 9, 2023 – (ACN Newswire) – A delegation of business leaders from the…
New survey shows consumers would readily switch their mobile provider for one that acted more…
IIIT Hyderabad uses the Choreo SaaS application development suite to provide “one-stop-shop” access to digital…
Munich, 09.02.2023 – A modern, timeless design and a wide range of options characterize the…
Bytes Technology Group to collaborate with AWS to scale migration and modernisation offerings on AWS…
Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by…
Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by…
Oslo, 9 February 2023: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel…
MONT-SAINT-GUIBERT, Belgium, Feb. 09, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 9, 2023 – Addex…